Ptc Therapeutics (PTCT) Return on Capital Employed (2013 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Return on Capital Employed of 2.98% in Q1 2026, down 106.19% quarter-over-quarter from 48.09% in Q4 2025, and down 4797.0% on a YoY basis from 0.06% in Q1 2025.
Ptc Therapeutics (PTCT) Return on Capital Employed (2013 - 2026) Analysis & Trends
Ptc Therapeutics' Return on Capital Employed history runs 14 years deep, the most recent figure standing at 2.98% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 4797.0% year-over-year to 2.98%; the TTM figure through Mar 2026 stood at 2.98% (down 4797.0% YoY), while the FY2025 annual figure was 65.01%, up 8983.0% from the prior year.
- Return on Capital Employed was 2.98% for Q1 2026 at Ptc Therapeutics, down from 48.09% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 48.09% in Q4 2025 to a low of 80.02% in Q3 2023.
- Historically, Return on Capital Employed has averaged 14.88% across 5 years, with a median of 26.06% in 2022.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed slumped 5390 bps in 2023, then jumped 7396 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 36.23% in 2022, then slipped by 24 bps to 45.09% in 2023, then soared by 44 bps to 25.37% in 2024, then soared by 290 bps to 48.09% in 2025, then tumbled by 106 bps to 2.98% in 2026.
- The last three Return on Capital Employed figures came in at 2.98% (Q1 2026), 48.09% (Q4 2025), and 43.77% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | -2.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.98% |
| Dec 31, 2025 | 48.09% |
| Sep 30, 2025 | 43.77% |
| Jun 30, 2025 | 35.62% |
| Mar 31, 2025 | 45.00% |
| Dec 31, 2024 | -25.37% |
| Sep 30, 2024 | -10.59% |
| Jun 30, 2024 | -15.93% |
| Mar 31, 2024 | -28.97% |
| Dec 31, 2023 | -45.09% |
| Sep 30, 2023 | -80.02% |
| Jun 30, 2023 | -59.74% |
| Mar 31, 2023 | -39.36% |
| Dec 31, 2022 | -36.23% |
| Sep 30, 2022 | -26.12% |
| Jun 30, 2022 | -28.89% |
| Mar 31, 2022 | -26.06% |
| Dec 31, 2021 | -25.59% |
| Sep 30, 2021 | -24.63% |
| Jun 30, 2021 | -19.40% |